Bioventix PLC (LON:BVXP – Get Free Report)’s share price hit a new 52-week low on Monday . The company traded as low as GBX 1,600 and last traded at GBX 1,628, with a volume of 11238 shares changing hands. The stock had previously closed at GBX 1,699.
Bioventix Stock Performance
The firm’s 50-day simple moving average is GBX 1,780.50 and its 200-day simple moving average is GBX 2,081.97. The company has a market capitalization of £84.48 million, a price-to-earnings ratio of 11.28 and a beta of 0.35.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Featured Stories
- Five stocks we like better than Bioventix
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
